FibroBiologics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Cash & Equivalents	9.16	2.27	0.41
Cash & Cash Equivalents	9.16	2.27	0.41
Cash Growth	304.37%	456.76%	-
Other Current Assets	0.05	0.36	0.06
Total Current Assets	9.22	2.63	0.47
Property, Plant & Equipment	2.61	2.2	0
Total Long-Term Assets	2.61	2.2	0
Total Assets	11.82	4.82	0.47
Accounts Payable	1.44	0.76	0.23
Current Debt	0.5	5.78	1.53
Other Current Liabilities	7.24	0.54	0
Total Current Liabilities	9.18	7.07	1.76
Long-Term Debt	1.39	1.75	0
Total Long-Term Liabilities	1.39	1.75	0
Total Liabilities	10.57	8.82	1.76
Total Debt	1.89	7.52	1.53
Debt Growth	-74.91%	393.38%	-
Retained Earnings	-24.36	-7.87	-2.75
Shareholders' Equity	1.25	-4	-1.29
Net Cash / Debt	7.28	-5.26	-1.12
Net Cash Per Share	0.26	-0.19	-
Working Capital	0.03	-4.45	-1.29
Book Value Per Share	0.04	-0.14	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).